Meditative neurofeedback for treating depression

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This open-label single-arm study aims to evaluate the effectiveness of a 10-session meditative neurofeedback intervention in alleviating symptoms of major depressive disorder. Participants will engage in neurofeedback sessions designed to enhance mindfulness and reduce rumination, with the goal of improving overall mood. The study will measure changes in depressive symptoms using standardized assessments, focusing on both primary and secondary outcomes related to mental health.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* moderate depression per PHQ9 symptom ratings

Exclusion Criteria:

* active substance abuse/dependence
* psychotic disorders
* bipolar disorder
* displaying acutely suicidal behaviors

Where it's running

• University of California San Diego
  La Jolla, California, United States Recruiting

Study contacts

• Study coordinator: Jyoti Mishra, PhD
• Email: braine@ucsd.edu
• Phone: 858-621-1517

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Digital twins to classify mental health patterns in adults with diabetes

  This project will try to create 'digital twin' profiles that combine glucose, mood, and behavior data to track mental health patterns in adults with diabetes.

  Recruiting Forschungsinstitut der Diabetes Akademie Mergentheim · Bad Mergentheim, Baden-Wurttemberg and 2 other locations · NCT07212075

• Heated yoga, sauna, or a mindfulness app for depression

  This project will test whether heated yoga, sauna sessions, or a mindfulness app reduce symptoms in adults with at least moderate depression.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT07082998

• CYB003, a deuterated psilocin, for adults with major depressive disorder

  This trial will test whether adding CYB003 to a current antidepressant helps reduce symptoms in adults with major depressive disorder who have not responded well to their medication.

  Recruiting at 51 sites Phase 3 Cybin IRL Limited · Birmingham, Alabama and 78 other locations · NCT06793397

• Understanding how the orbitofrontal cortex guides approach vs. avoidance in depression

  This study tests how different parts of the orbitofrontal cortex influence whether people pursue rewards or risk loss, and whether this pattern is altered in Major Depressive Disorder.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07896343

• Health education program to help depression in older adults and caregivers in Ho Chi Minh City

  A community-based education program for people 60+ and their caregivers is being tested to see if it can lower depression and improve quality of life compared with standard care.

  Recruiting University of Medicine and Pharmacy at Ho Chi Minh City · Ho Chi Minh City, Cho Lon · NCT07877571

• Prucalopride for low mood: testing a 5-HT4 receptor activator for cognition and sleep

  This study tests whether prucalopride, a 5-HT4 receptor drug, can improve thinking and sleep in adults with low mood or major depressive disorder compared to a placebo.

  Recruiting University of Oxford · Oxford, Oxfordshire · NCT07848477

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.